Omnicare (OCR) 57.82 $OCR
Omnicare Announces Conversion Rate Adjustment for Convertible Notes
Thomson Reuters ONE - Tue Apr 08, 6:31AM CDT
Omnicare's Series A and Series B Trust PIERS to Accrue Contingent Interest
Omnicare to Report First-Quarter 2014 Financial Results and Hold Conference Call on Wednesday, April 23, 2014
Thomson Reuters ONE - Wed Apr 02, 6:30AM CDT
CINCINNATI, April 2, 2014 - Omnicare, Inc. (NYSE:OCR) will release its financial results for the first-quarter of fiscal 2014 before the market opens on Wednesday, April 23, 2014.
Omnicare Unit Gets Accreditation but Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 12:00PM CDT
Shares of OCR have been on a downtrend since the announcement of its lower-than-expected earnings on Feb 19, 2014.
Health Care Equities Technical Momentum -- Research on Laboratory Corp. of America, Omnicare, DaVita HealthCare Partners, and MEDNAX
PR Newswire - Fri Mar 28, 9:17AM CDT
On Wednesday, March 26, 2014, the NASDAQ Composite finished at 4,173.58, down 1.43%, the Dow Jones Industrial Average fell by 0.60% to close the session at 16,268.99, and the S&P 500 ended the day at 1,852.56, down 0.70%. The losses were broad based with nine out of ten sectors ending the session in negative. The S&P 500 Health Care Sector Index finished the day at 672.05, up 0.05%, and the same has gained 4.63% in the last three months. Investor-Edge has initiated coverage on the following equities: Laboratory Corp. of America Holdings (NYSE: LH), Omnicare Inc. (NYSE: OCR), DaVita HealthCare Partners Inc. (NYSE: DVA), and MEDNAX Inc. (NYSE: MD). Free technical research on LH, OCR, DVA, and MD can be downloaded upon signing up at:
Recognitions, Board Elections, Acquisitions, and Organizational Changes - Analyst Notes on Omnicare, Cooper, Mednax, IDEXX, and Hologic
PR Newswire - Thu Mar 27, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Omnicare Inc. (NYSE: OCR), The Cooper Companies Inc. (NYSE: COO), MEDNAX, Inc. (NYSE: MD), IDEXX Laboratories, Inc. (NASDAQ: IDXX), and Hologic Inc. (NASDAQ: HOLX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
SmarTrend Watching for Potential Pullback in Shares of Omnicare After 1.17% Gain
Comtex SmarTrend(R) - Tue Mar 25, 4:57PM CDT
Omnicare (NYSE:OCR) traded in a range yesterday that spanned from a low of $58.25 to a high of $60.75. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $59.44 on volume of 2.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Trade-Ideas: Omnicare (OCR) Is Today's "Barbarian At The Gate" Stock
at The Street - Tue Mar 25, 9:31AM CDT
Trade-Ideas LLC identified Omnicare (OCR) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
Omnicare CEO to retire by year's end
AP - Tue Mar 25, 7:25AM CDT
CINCINNATI (AP) — Omnicare's John Workman will retire as CEO and board member by year's end.
Omnicare Announces CEO Transition Plan
Thomson Reuters ONE - Tue Mar 25, 6:31AM CDT
John Workman to Retire by End of 2014
May 17th Options Now Available For Omnicare (OCR)
DividendChannel.com - Mon Mar 24, 10:36AM CDT
Investors in Omnicare Inc. saw new options begin trading today, for the May 17th expiration.
Advanced Care Scripts Receives URAC Specialty Pharmacy Accreditation
Thomson Reuters ONE - Fri Mar 21, 6:31AM CDT
ORLANDO, March 21, 2014 - Advanced Care Scripts (ACS), a division of Omnicare Specialty Care Group (SCG), announced today that it has been awarded Specialty Pharmacy Accreditation from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry. URAC offers the only third-party, voluntary accreditation program of this scope for the pharmacy benefit management and prescription services industries.
Omnicare Set to Possibly Pullback After Yesterday's Rally of 1.40%
Comtex SmarTrend(R) - Mon Mar 17, 6:22PM CDT
Omnicare (NYSE:OCR) traded in a range yesterday that spanned from a low of $57.08 to a high of $58.03. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $57.85 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Omnicare Earnings Hindsight: Down 2.1% in Last 19 Days (OCR)
Comtex SmarTrend(R) - Mon Mar 10, 7:18AM CDT
19 days ago, on February 19th, 2014, Omnicare (NYSE:OCR) reported its earnings. Analysts, on average, expected earnings of $0.90 per share on sales of $1.6 billion. The company actually reported EPS of $0.90 on sales of $1.5 billion, missing EPS estimates by $0.00 and missing revenue estimates by $50.3 million. Since the company's report, shares of Omnicare have fallen from $60.98 to $59.68, representing a loss of 2.1% in the past 19 days.
3 Stocks Going Ex-Dividend Monday: TCAP, GLNG, OCR
at The Street - Fri Mar 07, 9:00AM CST
TCAP GLNG OCR are going ex-dividend Monday, Monday, March 10, 2014, 4:00 AM ET
Upgrade Alert for Omnicare (OCR)
Comtex SmarTrend(R) - Fri Mar 07, 7:06AM CST
Omnicare (NYSE:OCR) was upgraded from Neutral to Buy at UBS today. The stock closed yesterday at $57.73 on volume of 1.2 million shares, below average daily volume of 1.4 million. In the past 52 weeks, shares of Omnicare have traded between a low of $37.16 and a high of $64.87 and closed yesterday at $57.73, which is 55% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has declined 0.2%.
AG Gansler Secures $3.8 Million Settlement with Omnicare Inc. Maryland to receive nearly $67,000 to resolve kickback scheme allegations
M2 - Fri Mar 07, 3:30AM CST
Attorney General Douglas F. Gansler announced today that Maryland, joined by other states and the federal government, has secured a global settlement with Omnicare, Inc., a comprehensive provider of pharmacy and related services to long-term care and other specialized health care settings. The Maryland Medicaid program will receive $66,775.47, to be shared with the federal government, which provides a portion of Medicaid funding.
Omnicare to Pay Government $4.19 Million to Resolve False Claims Act Allegations of Kickbacks
M2 - Fri Feb 28, 6:17AM CST
Omnicare Inc., an Ohio-based long-term care pharmacy, has agreed to pay the government $4.19 million to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act, the Justice Department announced today. Omnicare provides pharmaceuticals and services to long-term care facilities and residents and other senior populations.
Grant & Eisenhofer Represents Whistleblower in Latest Settlement Involving Improper Marketing of Drug Used on Nursing Home Patients
PR Newswire - Thu Feb 27, 5:31PM CST
Following on the heels of a $24.9 million settlement with Amgen last April, long-term care pharmacy Omnicare (NYSE: OCR) has resolved allegations that it received remuneration from Amgen in order to influence the selection and utilization of the drug Aranesp throughout the nations' nursing homes. Aranesp, with limited indications, is used to treat anemia.
Omnicare Shares Up 53.6% Since SmarTrend's Buy Recommendation (OCR)
Comtex SmarTrend(R) - Thu Feb 27, 9:10AM CST
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on March 20th, 2013 at $38.92. In approximately 11 months, Omnicare has returned 53.62% as of today's recent price of $59.79.
Omnicare to Provide Medication Therapy Management Services for Certain Inland Empire Health Plan Members
Thomson Reuters ONE - Wed Feb 26, 7:01AM CST
CINCINNATI, February 26, 2014 - Omnicare, Inc. (NYSE: OCR) today announced it has partnered with Inland Empire Health Plan (IEHP) to provide Medication Therapy Management (MTM) services for the plan's members who reside in long-term care (LTC) facilities. Omnicare currently provides an MTM solution for WellCare Health Plans as well as several other health plans.
Omnicare Announces Conversion Rate Adjustment for Convertible Notes
Thomson Reuters ONE - Tue Apr 08, 6:31AM CDT
Omnicare's Series A and Series B Trust PIERS to Accrue Contingent Interest
Omnicare to Report First-Quarter 2014 Financial Results and Hold Conference Call on Wednesday, April 23, 2014
Thomson Reuters ONE - Wed Apr 02, 6:30AM CDT
CINCINNATI, April 2, 2014 - Omnicare, Inc. (NYSE:OCR) will release its financial results for the first-quarter of fiscal 2014 before the market opens on Wednesday, April 23, 2014.
Omnicare Unit Gets Accreditation but Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 12:00PM CDT
Shares of OCR have been on a downtrend since the announcement of its lower-than-expected earnings on Feb 19, 2014.
Health Care Equities Technical Momentum -- Research on Laboratory Corp. of America, Omnicare, DaVita HealthCare Partners, and MEDNAX
PR Newswire - Fri Mar 28, 9:17AM CDT
On Wednesday, March 26, 2014, the NASDAQ Composite finished at 4,173.58, down 1.43%, the Dow Jones Industrial Average fell by 0.60% to close the session at 16,268.99, and the S&P 500 ended the day at 1,852.56, down 0.70%. The losses were broad based with nine out of ten sectors ending the session in negative. The S&P 500 Health Care Sector Index finished the day at 672.05, up 0.05%, and the same has gained 4.63% in the last three months. Investor-Edge has initiated coverage on the following equities: Laboratory Corp. of America Holdings (NYSE: LH), Omnicare Inc. (NYSE: OCR), DaVita HealthCare Partners Inc. (NYSE: DVA), and MEDNAX Inc. (NYSE: MD). Free technical research on LH, OCR, DVA, and MD can be downloaded upon signing up at:
Recognitions, Board Elections, Acquisitions, and Organizational Changes - Analyst Notes on Omnicare, Cooper, Mednax, IDEXX, and Hologic
PR Newswire - Thu Mar 27, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Omnicare Inc. (NYSE: OCR), The Cooper Companies Inc. (NYSE: COO), MEDNAX, Inc. (NYSE: MD), IDEXX Laboratories, Inc. (NASDAQ: IDXX), and Hologic Inc. (NASDAQ: HOLX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
SmarTrend Watching for Potential Pullback in Shares of Omnicare After 1.17% Gain
Comtex SmarTrend(R) - Tue Mar 25, 4:57PM CDT
Omnicare (NYSE:OCR) traded in a range yesterday that spanned from a low of $58.25 to a high of $60.75. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $59.44 on volume of 2.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Trade-Ideas: Omnicare (OCR) Is Today's "Barbarian At The Gate" Stock
at The Street - Tue Mar 25, 9:31AM CDT
Trade-Ideas LLC identified Omnicare (OCR) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
Omnicare CEO to retire by year's end
AP - Tue Mar 25, 7:25AM CDT
CINCINNATI (AP) — Omnicare's John Workman will retire as CEO and board member by year's end.
Omnicare Announces CEO Transition Plan
Thomson Reuters ONE - Tue Mar 25, 6:31AM CDT
John Workman to Retire by End of 2014
May 17th Options Now Available For Omnicare (OCR)
DividendChannel.com - Mon Mar 24, 10:36AM CDT
Investors in Omnicare Inc. saw new options begin trading today, for the May 17th expiration.
Advanced Care Scripts Receives URAC Specialty Pharmacy Accreditation
Thomson Reuters ONE - Fri Mar 21, 6:31AM CDT
ORLANDO, March 21, 2014 - Advanced Care Scripts (ACS), a division of Omnicare Specialty Care Group (SCG), announced today that it has been awarded Specialty Pharmacy Accreditation from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry. URAC offers the only third-party, voluntary accreditation program of this scope for the pharmacy benefit management and prescription services industries.
Omnicare Set to Possibly Pullback After Yesterday's Rally of 1.40%
Comtex SmarTrend(R) - Mon Mar 17, 6:22PM CDT
Omnicare (NYSE:OCR) traded in a range yesterday that spanned from a low of $57.08 to a high of $58.03. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $57.85 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Omnicare Earnings Hindsight: Down 2.1% in Last 19 Days (OCR)
Comtex SmarTrend(R) - Mon Mar 10, 7:18AM CDT
19 days ago, on February 19th, 2014, Omnicare (NYSE:OCR) reported its earnings. Analysts, on average, expected earnings of $0.90 per share on sales of $1.6 billion. The company actually reported EPS of $0.90 on sales of $1.5 billion, missing EPS estimates by $0.00 and missing revenue estimates by $50.3 million. Since the company's report, shares of Omnicare have fallen from $60.98 to $59.68, representing a loss of 2.1% in the past 19 days.
3 Stocks Going Ex-Dividend Monday: TCAP, GLNG, OCR
at The Street - Fri Mar 07, 9:00AM CST
TCAP GLNG OCR are going ex-dividend Monday, Monday, March 10, 2014, 4:00 AM ET
Upgrade Alert for Omnicare (OCR)
Comtex SmarTrend(R) - Fri Mar 07, 7:06AM CST
Omnicare (NYSE:OCR) was upgraded from Neutral to Buy at UBS today. The stock closed yesterday at $57.73 on volume of 1.2 million shares, below average daily volume of 1.4 million. In the past 52 weeks, shares of Omnicare have traded between a low of $37.16 and a high of $64.87 and closed yesterday at $57.73, which is 55% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has declined 0.2%.
AG Gansler Secures $3.8 Million Settlement with Omnicare Inc. Maryland to receive nearly $67,000 to resolve kickback scheme allegations
M2 - Fri Mar 07, 3:30AM CST
Attorney General Douglas F. Gansler announced today that Maryland, joined by other states and the federal government, has secured a global settlement with Omnicare, Inc., a comprehensive provider of pharmacy and related services to long-term care and other specialized health care settings. The Maryland Medicaid program will receive $66,775.47, to be shared with the federal government, which provides a portion of Medicaid funding.
Omnicare to Pay Government $4.19 Million to Resolve False Claims Act Allegations of Kickbacks
M2 - Fri Feb 28, 6:17AM CST
Omnicare Inc., an Ohio-based long-term care pharmacy, has agreed to pay the government $4.19 million to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act, the Justice Department announced today. Omnicare provides pharmaceuticals and services to long-term care facilities and residents and other senior populations.
Grant & Eisenhofer Represents Whistleblower in Latest Settlement Involving Improper Marketing of Drug Used on Nursing Home Patients
PR Newswire - Thu Feb 27, 5:31PM CST
Following on the heels of a $24.9 million settlement with Amgen last April, long-term care pharmacy Omnicare (NYSE: OCR) has resolved allegations that it received remuneration from Amgen in order to influence the selection and utilization of the drug Aranesp throughout the nations' nursing homes. Aranesp, with limited indications, is used to treat anemia.
Omnicare Shares Up 53.6% Since SmarTrend's Buy Recommendation (OCR)
Comtex SmarTrend(R) - Thu Feb 27, 9:10AM CST
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on March 20th, 2013 at $38.92. In approximately 11 months, Omnicare has returned 53.62% as of today's recent price of $59.79.
Omnicare to Provide Medication Therapy Management Services for Certain Inland Empire Health Plan Members
Thomson Reuters ONE - Wed Feb 26, 7:01AM CST
CINCINNATI, February 26, 2014 - Omnicare, Inc. (NYSE: OCR) today announced it has partnered with Inland Empire Health Plan (IEHP) to provide Medication Therapy Management (MTM) services for the plan's members who reside in long-term care (LTC) facilities. Omnicare currently provides an MTM solution for WellCare Health Plans as well as several other health plans.
